Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqgirl123
    Member
    • Oct 2008
    • 78

    #1

    Agilent XT2 kit

    I can't use the XT2 blocking oligos because my libraries are 6nt indices and Agilent XT2 only support 8nt indices. I'm thinking of purchasing the Xgen blocking oligos.

    Has anyone tried using the Xgen IDT blocking oligos (6nt index) with the Agilent Sureselect XT2 kit? Once I add the Xgen blocking oligos to my gDNA library pool and dry down to 7ul, will I add the Sureselect XT2 blocking mix (it specifies to add 9ul of blocking mix to your 7ul dried down volume in the protocol), or will I completely skip the addition of the XT2 blocking mix and go straight to adding RNase block and capture library? And does anyone know the usefulness or components of the XT2 blocking mix? If I didn't add Sureselect XT2 blocking mix and since I have my added my own Xgen blocking oligos, that should suffice correct? Or is there anything particular in the XT2 blocking mix. I only know it it will blocks the indices and universal sequence during capture, but the Xgen blocking oligos will do the same correct?
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    You might find some useful information in this tread: http://seqanswers.com/forums/showthr...hlight=capture

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:13 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Working...